Clinical Trial: Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders.
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A 1-Year Open-Label Safety Extension Study of Pregabalin in Patients With Anxiety Disorders
Brief Summary: Determine long-term safety and tolerability of pregabalin in patients with anxiety disorders.
Detailed Summary:
Sponsor: Pfizer
Current Primary Outcome: Safety Tolerability
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Pfizer
Dates:
Date Received: September 6, 2005
Date Started: January 2001
Date Completion: March 2006
Last Updated: July 13, 2006
Last Verified: July 2006